Meet our Investigators
Given the size of the Global Leukodystrophy Initiative (GLIA) and its collaborative stakeholders, covering a group of related yet distinct conditions, a strength of our application is that we have harnessed the commitment of multiple investigators to ensure that the GLIA-CTN can operate seamlessly at a national level. Each of these investigators brings extensive and complementary experience in different areas of expertise. They have each been tasked with managing various aspects of the program, and they will work closely with each other - as well as our external stakeholders - to ensure the success of the GLIA-CTN.
Laura A. Adang, MD, PhD
Children's Hospital of Philadelphia
Philadelphia, PA
Amy J. Bastian, PhD, PT
Kennedy Krieger Institute
Baltimore, MD
Joshua L. Bonkowsky, MD, PhD
University of Utah Health
Salt Lake City, UT
Lisa T. Emrick, MD
Texas Children's Hospital
Houston, TX
Florian Eichler, MD
Massachusetts General Hospital
Boston, MA
S. Ali Fatemi, MD, MBA
Kennedy Krieger Institute
Baltimore, MD
Jamie L. Fraser, MD, PhD
Children’s National Medical Center
Washington, DC
Stephanie Keller, MD
Emory University
Atlanta, GA
Richard F. Lewis, MD
Massachusetts General Hospital
Boston, MA
Eric J. Mallack, MD
Weill Cornell Medical Center
New York, NY
Albee Messing, VMD, PhD
University of Wisconsin–Madison
Madison, WI
Christopher Stephen, MBChB
Massachusetts General Hospital
Boston, MA
Asako Takanohashi, PhD, DMV
Children's Hospital of Philadelphia
Philadelphia, PA
Adeline L. Vanderver, MD
Children's Hospital of Philadelphia
Philadelphia, PA
Keith P. Van Haren, MD
Stanford Children's Health
Palo Alto, CA
Amy T. Waldman, MD, MSCE
Children's Hospital of Philadelphia
Philadelphia, PA